Advertisement
Advertisement

SNY

SNY logo

Sanofi - ADR

44.06
USD
Sponsored
+0.09
+0.19%
Mar 17, 15:59 UTC -4
Closed
exchange

Pre-Market

44.20

+0.14
+0.32%

SNY Earnings Reports

Positive Surprise Ratio

SNY beat 31 of 40 last estimates.

78%

Next Report

Date of Next Report
Apr 23, 2026
Estimate for Q1 26 (Revenue/ EPS)
$10.36B
/
$1.79
Implied change from Q4 25 (Revenue/ EPS)
-8.31%
/
+16.99%
Implied change from Q1 25 (Revenue/ EPS)
+4.74%
/
--

Sanofi - ADR earnings per share and revenue

On Jan 29, 2026, SNY reported earnings of 1.53 USD per share (EPS) for Q4 25, beating the estimate of 1.46 USD, resulting in a 4.58% surprise. Revenue reached 11.30 billion, compared to an expected 11.54 billion, with a -2.08% difference. The market reacted with a +0.94% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 1.79 USD, with revenue projected to reach 10.36 billion USD, implying an increase of 16.99% EPS, and decrease of -8.31% in Revenue from the last quarter.
FAQ
For Q4 2025, Sanofi - ADR reported EPS of $1.53, beating estimates by 4.58%, and revenue of $11.30B, -2.08% below expectations.
The stock price moved up 0.94%, changed from $45.77 before the earnings release to $46.20 the day after.
The next earning report is scheduled for Apr 23, 2026.
Based on 4 analysts, Sanofi - ADR is expected to report EPS of $1.79 and revenue of $10.36B for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement